Comments
Loading...
Zentalis Pharma (ZNTL) Forecast
NewsEarningsZentalis Pharma (ZNTL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestZentalis Pharma (NASDAQ:ZNTL) Stock Quotes, Forecast and News Summary
Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zentalis Pharma (ZNTL) stock?
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Who are Zentalis Pharma (ZNTL) competitors?
Other companies in Zentalis Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY) and Fate Therapeutics (NASDAQ:FATE).
What is the forecast, or price target, for Zentalis Pharma (ZNTL) stock?
Zentalis Pharma has a consensus price target of $18.10.
What is the current price for Zentalis Pharma (ZNTL)?
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $2.93 last updated December 18, 2024 at 1:37 PM EST.
Does Zentalis Pharma (ZNTL) pay a dividend?
There are no upcoming dividends for Zentalis Pharma.
When is Zentalis Pharma (NASDAQ:ZNTL) reporting earnings?
Zentalis Pharma’s FY earnings are confirmed for Tuesday, February 25, 2025.
Is Zentalis Pharma (ZNTL) going to split?
There is no upcoming split for Zentalis Pharma.
What sector and industry does Zentalis Pharma (ZNTL) operate in?
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.